|
|
|
|
RA Adan, RD Cone, JP Burbach and WH Gispen
Rudolf Magnus Institute for Neuroscience, Department of Medical Pharmacology, Utrecht University, The Netherlands.
Melanocortins (MCs) have various physiological actions on the brain. The recent cloning of neural MC receptors opened new avenues to study the effects of these neuropeptides on the nervous system. Here we investigated the structure-activity relationships (SARs) of peptides derived from adrenocorticotropic hormone (ACTH) with cloned MC3 and MC4 receptors in vitro and correlated these with central effects of MCs in vivo. Analysis of the effects of various MC peptides on cAMP accumulation in and binding to cells that expressed either the rat MC3 receptor or the human MC4 receptor demonstrated that ACTH-4-9-NH2 was the core sequence of ACTH able to activate these receptors. Furthermore, gamma-melanocyte-stimulating hormone (MSH) displayed selectivity for the MC3 receptor, whereas [D-Phe7]ACTH-4-10 more efficiently activated the MC4 receptor than the MC3 receptor. The activities of MC fragments that lacked the three carboxyl-terminal amino acids (residues 11-13) of ACTH-1-13 were much lower than that of alpha-MSH, for both receptors. Furthermore, the three amino-terminal amino acids (residues 1-3) of alpha-MSH were more important for full activation of the MC4 receptor, compared with the MC3 receptor. The SAR for the MC4 receptor resembled that for the induction of excessive grooming behavior by MC peptides. Therefore, we suggest that this behavioral response is mediated by MC4 receptors. The SAR for the MC3 receptor did not overlap with that for in vivo effects of MCs. ORG2766, an ACTH-4-9 analog that is very potent in an active avoidance task, did not activate, antagonize, or bind to the MC3 and MC4 receptors. This suggests the presence of still other MC receptors, in addition to the MC3 and MC4 receptors, in the brain. These data identify peptides with selectivity for either the MC3 receptor or the MC4 receptor, which may be used for development of novel MC receptor-specific ligands. Furthermore, this is the first report that discusses behavioral effects of MCs in light of data on cloned MC receptors.
This article has been cited by other articles:
![]() |
J. L. Trevaskis, E. A. Meyer, J. E. Galgani, and A. A. Butler Counterintuitive Effects of Double-Heterozygous Null Melanocortin-4 Receptor and Leptin Genes on Diet-Induced Obesity and Insulin Resistance in C57BL/6J Mice Endocrinology, January 1, 2008; 149(1): 174 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Krude, H. Biebermann, D. Schnabel, M. Z. Tansek, P. Theunissen, P. E. Mullis, and A. Gruters Obesity Due to Proopiomelanocortin Deficiency: Three New Cases and Treatment Trials with Thyroid Hormone and ACTH4-10 J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4633 - 4640. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Clegg, S. C. Benoit, E. L. Air, A. Jackman, P. Tso, D. D'Alessio, S. C. Woods, and R. J. Seeley Increased Dietary Fat Attenuates the Anorexic Effects of Intracerebroventricular Injections of MTII Endocrinology, July 1, 2003; 144(7): 2941 - 2946. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Clegg, C. A. Riedy, K. A. B. Smith, S. C. Benoit, and S. C. Woods Differential Sensitivity to Central Leptin and Insulin in Male and Female Rats Diabetes, March 1, 2003; 52(3): 682 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Hwa, L. Ghibaudi, J. Gao, and E. M. Parker Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R444 - R451. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Fehm, R. Smolnik, W. Kern, G. P. McGregor, U. Bickel, and J. Born The Melanocortin Melanocyte-Stimulating Hormone/Adrenocorticotropin4-10 Decreases Body Fat in Humans J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1144 - 1148. [Abstract] [Full Text] |
||||
![]() |
L. Langouche, M. Roudbaraki, K. Pals, and C. Denef Stimulation of Intracellular Free Calcium in GH3 Cells by {{gamma}}3-Melanocyte-Stimulating Hormone. Involvement of a Novel Melanocortin Receptor? Endocrinology, January 1, 2001; 142(1): 257 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Benoit, M. W. Schwartz, J. L. Lachey, M. M. Hagan, P. A. Rushing, K. A. Blake, K. A. Yagaloff, G. Kurylko, L. Franco, W. Danhoo, et al. A Novel Selective Melanocortin-4 Receptor Agonist Reduces Food Intake in Rats and Mice without Producing Aversive Consequences J. Neurosci., May 1, 2000; 20(9): 3442 - 3448. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fekete, G. Legradi, E. Mihaly, Q.-H. Huang, J. B. Tatro, W. M. Rand, C. H. Emerson, and R. M. Lechan alpha -Melanocyte-Stimulating Hormone Is Contained in Nerve Terminals Innervating Thyrotropin-Releasing Hormone-Synthesizing Neurons in the Hypothalamic Paraventricular Nucleus and Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Gene Expression J. Neurosci., February 15, 2000; 20(4): 1550 - 1558. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Hagan, P. A. Rushing, M. W. Schwartz, K. A. Yagaloff, P. Burn, S. C. Woods, and R. J. Seeley Role of the CNS Melanocortin System in the Response to Overfeeding J. Neurosci., March 15, 1999; 19(6): 2362 - 2367. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Grill, A. B. Ginsberg, R. J. Seeley, and J. M. Kaplan Brainstem Application of Melanocortin Receptor Ligands Produces Long-Lasting Effects on Feeding and Body Weight J. Neurosci., December 1, 1998; 18(23): 10128 - 10135. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Ludwig, K. G. Mountjoy, J. B. Tatro, J. A. Gillette, R. C. Frederich, J. S. Flier, and E. Maratos-Flier Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E627 - E633. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-P. Ni, R. A. Kesterson, S. D. Sharma, V. J. Hruby, R. D. Cone, E. Wiedemann, and M. H. Humphreys Prevention of reflex natriuresis after acute unilateral nephrectomy by melanocortin receptor antagonists Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R931 - R938. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Li, K. Varga, P. Archer, V. J. Hruby, S. D. Sharma, R. A. Kesterson, R. D. Cone, and G. Kunos Melanocortin Antagonists Define Two Distinct Pathways of Cardiovascular Control by alpha - and gamma -Melanocyte-Stimulating Hormones J. Neurosci., August 15, 1996; 16(16): 5182 - 5188. [Abstract] [Full Text] [PDF] |
||||